Related Experiment Videos
Summary
This study investigated alphafetoprotein (AFP) in bilharziasis patients. While AFP was detected in nearly half, it has limited value as a screening tool for this parasitic disease.
Area of Science:
- Medical Parasitology
- Clinical Chemistry
- Immunology
Background:
- Bilharziasis, caused by Schistosoma haematobium, is endemic in many regions.
- Alphafetoprotein (AFP) is a biomarker of potential interest in various diseases.
Purpose of the Study:
- To investigate the prevalence of alphafetoprotein (AFP) in patients diagnosed with bilharziasis.
- To assess the utility of AFP detection as a screening method for bilharziasis.
Main Methods:
- Serum samples from 284 patients with confirmed Schistosoma haematobium infection were analyzed for AFP.
- Radioimmunoassay (RIA) was employed for AFP detection.
Main Results:
- Nearly half (49.6%) of the patients tested positive for AFP.
- No false positive results for AFP were observed in the study cohort.
- Radioimmunoassay demonstrated potential to further increase the detection rate of AFP.
Conclusions:
- AFP detection in serum shows a notable prevalence in bilharziasis patients.
- AFP screening has limited practical value for diagnosing bilharziasis in endemic areas.
- Further research may explore the role of AFP in specific contexts of schistosomiasis.